Iron complexes of the cardioprotective agent dexrazoxane (ICRF-187) and its desmethyl derivative, ICRF-154: solid state structure, solution thermodynamics, and DNA cleavage activity-Reference-Cited by-同舟云学术

Iron complexes of the cardioprotective agent dexrazoxane (ICRF-187) and its desmethyl derivative, ICRF-154: solid state structure, solution thermodynamics, and DNA cleavage activity

Published:2000-02 Issue:3 Volume:78 Page:209-216
ISSN:0162-0134
Container-title:Journal of Inorganic Biochemistry
language:en
Short-container-title:Journal of Inorganic Biochemistry

Author:

Diop Ndeye Khady,Vitellaro Lizabeth K,Arnold Paul,Shang Maoyu,Marusak Rosemary A

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Biochemistry

Reference37 articles.

1. Reduction of Doxorubicin-Induced Cardiotoxicity by Dexrazoxane

2. The one-ring open hydrolysis product intermediates of the cardioprotective agent ICRF-187 (dexrazoxane) displace iron from iron-anthracycline complexes

3. Metal ion-promoted hydrolysis of the antioxidant cardioprotective agent dexrazoxane (ICRF-187) and its one-ring open hydrolysis products to its metal-chelating active form

4. B. Halliwell, J.M.C. Gutteridge, Free Radicals in Biology and Medicine, 2nd ed., Clarendon, Oxford, 1989.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing of Various Current Medicines as Radioprotective Agents;Anti-Cancer Agents in Medicinal Chemistry;2023-06

2. Preventive Therapy;Anti-Cancer Treatments and Cardiotoxicity;2017

3. Utility of Dexrazoxane for the Attenuation of Epirubicin-Induced Genetic Alterations in Mouse Germ Cells;PLOS ONE;2016-09-30

4. A review of the preclinical development of dexrazoxane;Progress in Pediatric Cardiology;2014-09

5. Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits;Toxicology;2013-09